BlackRock, Inc. 13D and 13G filings for Voyager Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-08-07 4:10 pm Purchase |
2024-07-31 | 13G | Voyager Therapeutics, Inc. VYGR |
BlackRock Inc. BLK |
5,459,941 10.000% |
2,827,262 (+107.39%) |
Filing |
| 2024-01-29 5:25 pm Purchase |
2023-12-31 | 13G | Voyager Therapeutics, Inc. VYGR |
BlackRock Inc. BLK |
2,632,679 6.000% |
1,690,013 (+179.28%) |
Filing |
| 2021-07-12 08:29 am Sale |
2021-06-30 | 13G | Voyager Therapeutics, Inc. VYGR |
BlackRock Inc. BLK |
942,666 2.500% |
-1,587,065 (-62.74%) |
Filing |
| 2021-02-01 08:30 am Purchase |
2020-12-31 | 13G | Voyager Therapeutics, Inc. VYGR |
BlackRock Inc. BLK |
2,529,731 6.800% |
412,537 (+19.49%) |
Filing |